Copyright
©The Author(s) 2025.
World J Gastroenterol. Jul 28, 2025; 31(28): 109468
Published online Jul 28, 2025. doi: 10.3748/wjg.v31.i28.109468
Published online Jul 28, 2025. doi: 10.3748/wjg.v31.i28.109468
Figure 1 Various endoscopic bariatric and metabolic therapies currently available.
DJBL: Duodenojejunal bypass liner; DJBS: Duodenojejunal bypass sleeve; IRE: Irreversible electroporation; ReCET: Recellularization using electroporation therapy.
- Citation: Fernandez CJ, Jena S, Lakshmi V, Pappachan JM. Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2025; 31(28): 109468
- URL: https://www.wjgnet.com/1007-9327/full/v31/i28/109468.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i28.109468